In contrast, allo-HCT offers the potential for long-term disease control through a graft-vs-tumor effect, in which donor ...
Myelodysplastic syndromes (MDS) are malignant disorders arising from hematopoietic stem cells, yet the precise epigenetic abnormalities occurring in the primitive stem cells remain poorly understood.
LYT-200 plus HMA at 12 mg/kg delivered 45.5% ORR in 11 R/R HR-MDS patients, including 27.3% CRs, despite 100% prior HMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results